SCHEDULE: Morgan Stanley Adjusts Omada Health Stake

Morgan Stanley has reported a change in its beneficial ownership of Omada Health, Inc. common stock, now holding 5.3% of the class.

Summary

• Morgan Stanley has filed a Schedule 13G, indicating a change in its beneficial ownership of Omada Health, Inc. common stock.
• The filing states that Morgan Stanley beneficially owns 3,214,347 shares, representing 5.3% of the class of securities.
• This filing is made under Rule 13d-1(b) and Morgan Stanley is identified as a broker or dealer registered under section 15 of the Act.
• The reporting entity is Morgan Stanley, a Delaware-organized entity.
• The filing date is September 30, 2026, with the signature date of November 13, 2026.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership without significant new financial or strategic information.

Future Outlook

No forward-looking statements or guidance are provided in this filing.

Management Comments

• "In Accordance with the Securities and Exchange Commission Release No. 34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by certain operating units (collectively, the "MS Reporting Units") of Morgan Stanley and its subsidiaries and affiliates (collectively, "MS")."
• "This filing does not reflect securities, if any, beneficially owned by any operating units of MS whose ownership of securities is disaggregated from that of the MS Reporting Units in accordance with the Release."
• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors crossing certain ownership thresholds, indicating a significant but not controlling stake. This filing by Morgan Stanley, a major financial institution, is typical for its role as a broker-dealer managing client assets or proprietary positions.

Stakeholder Impact

• Shareholders: The filing provides transparency regarding institutional ownership, which can be a factor in market perception and trading activity.

Key Dates

Keywords

Omada Health, Morgan Stanley, Schedule 13G, Beneficial Ownership, Common Stock, Securities Exchange Act